IFN Beta is quantifiable in 86% of MS patients on IFN Beta therapy, 4.1% of MS patients on other therapies and 1.5% of Normal Donor samples.
IFN Beta is quantifiable in 86% of MS patients on IFN Beta therapy, 4.1% of MS patients on other therapies and 1.5% of Normal Donor samples.
Interferon-beta (IFN-beta) Serum ELISA Kit
PBL41415-1
Product group Assays
Overview
- SupplierOriGene
- Product NameInterferon-beta (IFN-beta) Serum ELISA Kit
- Delivery Days Customer14
- ApplicationsELISA
- CertificationResearch Use Only
- UNSPSC41116158